Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry

Although it's not yet clear how health care providers will respond to value-based payment models, an examination of pharmaceutical industry practices can provide insights into problems that may arise — and practices to avoid. In 2015, the U.S. Department of Health and Human Services announced a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine Jg. 375; H. 21; S. 2013 - 2015
Hauptverfasser:	Dafny, Leemore S, Ody, Christopher J, Schmitt, Matthew A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Massachusetts Medical Society 24.11.2016
Schlagworte:	Brand names Consumers Cost Sharing Discount coupons Drug Costs Drug Industry - economics Medicare - economics Pharmaceutical industry Prescription drugs Prescription Fees United States Value-Based Purchasing United States > US Virginia
ISSN:	0028-4793, 1533-4406
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!